Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W McGory

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Pharmacy|January 1, 1983
Hemodialysis clearance of total and unbound lidocaineJ Jacobi, R W McGory, H McCoy, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Pharmacokinetics of vancomycin in patients with various degrees of renal functionG R Matzke, R W McGory, C E Halstenson, et al.
Anesthesia and Analgesia|October 1, 1990
Hemodynamic effects of rapid vancomycin infusion in critically ill patientsG R Stier, R W McGory, W D Spotnitz, et al.
Transplantation Proceedings|November 18, 2009
Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipientsT L Pruett, R W McGory, F H Wright, et al.
Clinical Transplantation|December 1, 1996
Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunizationB al-Hemsi, R W McGory, B Shepard, et al.
Transplantation|May 15, 1996
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunizationR W McGory, M B Ishitani, W M Oliveira, et al.
Annals of Surgery|June 24, 1998
Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunizationR G Sawyer, R W McGory, M J Gaffey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Pharmacy|January 1, 1983
Hemodialysis clearance of total and unbound lidocaineJ Jacobi, R W McGory, H McCoy, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Pharmacokinetics of vancomycin in patients with various degrees of renal functionG R Matzke, R W McGory, C E Halstenson, et al.
Anesthesia and Analgesia|October 1, 1990
Hemodynamic effects of rapid vancomycin infusion in critically ill patientsG R Stier, R W McGory, W D Spotnitz, et al.
Transplantation Proceedings|November 18, 2009
Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipientsT L Pruett, R W McGory, F H Wright, et al.
Clinical Transplantation|December 1, 1996
Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunizationB al-Hemsi, R W McGory, B Shepard, et al.
Transplantation|May 15, 1996
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunizationR W McGory, M B Ishitani, W M Oliveira, et al.
Annals of Surgery|June 24, 1998
Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunizationR G Sawyer, R W McGory, M J Gaffey, et al.
Pageof 1